Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to anticancer treatment - Archive ouverte HAL Access content directly
Journal Articles Seminars in Cancer Biology Year : 2017

Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to anticancer treatment

(1) , (1) , (1) , (1) , (1) , (1) , (1) , (1)
1

Abstract

While tumours arise from acquired mutations in oncogenes or tumour-suppressor genes, it is clearly established that cancers are metabolic diseases characterized by metabolic alterations in tumour cells, and also non-tumour cells of the host organism resulting in tumour cachexia and patient weakness. In this review, we aimed at delineating details by which metabolic alterations in cancer cells, characterized by mitochondrial bioenergetics deregulations and the preference for aerobic glycolysis, are critical parameters controlling the aggressive progression of tumours. In particular, metabolic alteration in cancer cells are coupled to the modulation of intracellular and extracellular pH, epithelial-to-mesenchymal transition and associated increased invasiveness, autophagy, and the development of anticancer treatment resistance. Finally, based on mechanistic, pre-clinical and clinical studies, we proposed the adjuvant supplementation of dietary n-3 polyunsaturated fatty acids for a complementary holistic treatment of the cancer disease.
Fichier principal
Vignette du fichier
Dumas et al., Seminars in Cancer Biology_revised.pdf (452.42 Ko) Télécharger le fichier
Vignette du fichier
Dumas YSCBI Figures.pdf (3.5 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01907572 , version 1 (20-08-2020)

Identifiers

Cite

Jean-François Dumas, Lucie Brisson, Stephan Chevalier, Karine Mahéo, Gaëlle Fromont, et al.. Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to anticancer treatment. Seminars in Cancer Biology, 2017, The new pH-centric Anticancer Paradigm in Oncology and Medicine, 43, pp.90-110. ⟨10.1016/j.semcancer.2017.03.004⟩. ⟨hal-01907572⟩

Collections

INSERM UNIV-TOURS
103 View
319 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More